In retinitis pigmentosa (RP), a majority of causative mutations affect genes solely expressed in rods; however cone degeneration inevitably follows rod cell loss. Following transplantation and in vitro studies we demonstrated the role of photoreceptor cell paracrine interactions and identified a Rod-derived-Cone Viability Factor, RdCVF, which increases cone survival. In order to establish the clinical relevance of such mechanism, we assessed the functional benefit afforded by the injection of this factor in a frequent type of rhodopsin mutation, the P23H rat. In this model of autosomal dominant RP, RdCVF expression decreases in parallel with primary rod degeneration, which is followed by cone loss. RdCVF 
INTRODUCTION
Retinitis Pigmentosa is a photoreceptor degenerative disease caused by various mutations affecting many different genes [1] . Whereas most causative genes are selectively expressed in rod photoreceptors [2, 3] , a sequential rod-cone photoreceptor loss is observed in humans as well as in animal models, which is reflected by the designation of this condition as a rod-cone dystrophy. In clinical terms, while the loss of the rod photoreceptors leads to darkadapted vision loss, the most feared visual impairment is the consequence of the secondary cone photoreceptor loss, as this cell population is necessary for diurnal vision, including photopic visual field, visual acuity, color perception and contrast sensitivity [4] . Therefore the development of therapeutic strategies targeting the mechanisms underlying the secondary cone cell death in RP represents a very promising approach. This could be applied in a wide range of mutations expressed in rods, even at late stages of the disease as it has been shown that vision may remain substantial even when 95% of cones have been lost [5] . In other words, keeping the functional cones alive may prevent up to 1.5 million people worldwide becoming blind [6] .
We previously studied the rod-cone cellular interactions and proposed, following photoreceptor transplantation studies in the rd1 mouse that the secondary cone degeneration could be significantly diminished by a surviving signal, released by rods or requiring their presence [7, 8] . We subsequently demonstrated in vitro that these rod-cone interactions are mediated by secreted proteins [9, 10] . A systematic expression cloning strategy then enabled us to isolate a Rod-derived Cone Viability Factor (RdCVF) encoded by the Nxnl1 (Txnl6) gene [11] . This factor is able to rescue cone photoreceptors in the rd1 mouse. We could not assess the functionality of the rescued cones as, at the age of RdCVF injection, i.e. once rods inserm-00464512, version 1 -17 Mar 2010 had degenerated, the rd1 mouse no longer presented a measurable electroretinogram (ERG) [12] .
In order to validate the therapeutic interest of RdCVF in RP, we performed this study aimed at demonstrating its functional benefit. We have selected a larger animal model carrying a prevalent RP gene mutation, the transgenic rhodopsin P23H mutant rat. This corresponds to the most frequent autosomal dominant human RP mutation observed in 12% of autosomal dominant patients in the United States [1] while the rd1 mouse is affected by a mutation in the rod specific beta subunit gene of the cGMP-dependent phosphodiesterase 6 [13] , responsible for less than 5% of autosomal-recessive RP in humans.
We characterized the course of cone photoreceptor degeneration in the P23H rat at both electrophysiological and histological levels and assessed these parameters following RdCVF protein injection. The study provides the first evidence for a functional rescue of cone photoreceptor following RdCVF administration in an animal model of RP. Moreover, our results support a possible role of RdCVF in the maintenance of the functionality of cones [14] .
The clinical significance of such functional rescue cannot be underestimated, in view of the reported discrepancy between the morphological and functional effects on photoreceptor cells of another neuroprotective agent [15] , ciliary neurotrophic factor (CNTF), currently in phase II clinical trials [16] .
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RESULTS
Secondary cone loss follows rod cell death in the P23H transgenic rats
In the P23H rat model, a transgene corresponding to the P23H mutated mouse rhodopsin gene is expressed under the control of the rhodopsin promoter, and thus expressed selectively by rod photoreceptors [17] . Histology sections show progressive thinning and loss of outer segments and outer nuclear layer between 2 to 8 months corresponding to rod loss in the heterozygotous P23H rats as previously published [18, result not shown] . Figure 1a shows the decrease of cone density, estimated by stereological cell counting from 3 to 9 months. By six months of age most rods have degenerated while only 41% of cones have been lost with a further 28% loss of cones between 6 and 9 months.
Functional assessment performed by ERG recordings shows a loss of scotopic and photopic function during photoreceptor degeneration (Figs. 1b-e) . The average amplitude of the scotopic ERG B-wave was reduced by 75% between 2 and 4 months (from 268 µV to 66 µV; Fig. 1d and Table 1) , and was further reduced by up to 89% at 9 months (29 µV), while the photopic ERG B-wave amplitude decreased by, respectively 56% (77 µV versus 34 µV) and 77% (18 µV) during the same periods. Loss of cone function was further confirmed by flicker ERG (Fig. 1e) .
Thus, as observed for the rd1 mouse [9, 11, 19] , rod degeneration, triggered here by the expression of the mutant protein in rod cells, is followed by a secondary loss of cones through a non-cell-autonomous mechanism. The sequential degeneration of rods and cones in the heterozygotous P23H model makes it therefore an appropriate model for the assessment of cone rescue strategies.
Decreased RdCVF expression correlates with rod loss in the P23H rat model
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We then investigated the expression of RdCVF, a trophic factor expressed in a roddependent manner in the mouse [11] . Mouse RdCVF-L protein sequence (Uniprot: Q8VC33) was used to identify the rat RdCVF sequence (Figs. 2a,b) . As for the mouse Nxnl1 (Txnl6) and Nxnl2 genes, different forms of RdCVF mRNAs were identified resulting most likely from alternative splicing [20] . Using RT-PCR, RdCVF-Total expression (short and long forms) was found to be expressed in the neural retina but not in the retinal pigment epithelium of the rat (Fig. 3a) . Using specific primers we quantified by real-time RT-PCR the expression of RdCVF and RdCVF-L mRNAs. The steady state level of RdCVF total mRNAs increases gradually during the period from PN10 to PN30 in wild-type retinas, however in P23H retinas it reaches a maximum expression at PN20 (lower than that in wild-type at this stage) then decreases by PN30 (Fig. 3b) . -actin was used as an internal control and the relative expression of RdCVF was 27% and 7% in the Sprague-Dawley (SD) and Pro23His rat retinas respectively, they represent only 1.1% and 0.8% in the P23H rat retina at 6 months of age, after rod photoreceptors have been lost. Quantitative RT-PCR also shows a rod-dependent expression matching that of rod arrestin (result not shown). To confirm the rod-dependent expression of RdCVF, we analyzed by western blotting the expression of RdCVF during the course of rod photoreceptor maturation and degeneration in the P23H rat retina using RdCVF-N rabbit polyclonal antibodies [11] . The intensity of the band corresponding to RdCVF-L is shown to increase during the maturation of the retina between PN10 and 3 months in the wildtype rat but up to 2 months in the P23H rat (Fig. 3c) . For the P23H retina the RdCVF-L expression lags behind that of normal retina and starts to decrease from 2.5 to 4 months, the period of rod loss. The reduced RdCVF-L immunoreactivity in wild-type retina is most likely reflecting a loading difference as seen on the top panel. A non-specific band migrating at the position of the short isoform of RdCVF interferes with quantitative analysis. However in spite of this, a decrease in expression may still be seen at 4 months. We next localized RdCVF inserm-00464512, version 1 -17 Mar 2010 expression in the retina by immunohistochemistry using the same antibodies. The expression of the Nxnl1 (Txnl6) gene products could be detected in the SD retina at PN10 with increasing expression to 3 months at which stage stable expression is achieved up to 5 months of age (Fig. 3d) . This expression pattern matches that of rhodopsin in the rod outer segments at the same period. Also, in P23H rat retina, RdCVF labeling is localized to the photoreceptor outer segments, but decreases as the segments shorten (3 to 5 months).
Subretinal injections of RdCVF protein delay both cone cell death and photopic visual loss
RdCVF protein (109 aa) was chemically synthesized (>90% purity) and refolded (Fig.   4a ). The activity of the synthesized protein was measured using an in vitro cone-enriched culture system. As, when compared to a fusion protein purified after expression in E. coli, the synthesized protein showed equivalent protective activity and was of higher purity, the latter was consequently used for injection (Fig. 4b, result not shown) . Three injections of the synthesized polypeptide (1.5 µg) were performed at different time point (separately at the age of 6, 7, 8 month) in the sub-retinal space of the P23H rats. PBS was injected as negative control (SM). The cone density in the RdCVF injected eyes (1790±231 c/mm²) at 9 months of age, one month after the last subretinal injection, was increased by 19% compared to the sham controls (1498±141 c/mm²) and by 20% compared to the contralateral controls (1497±133 c/mm², Fig. 4c) . Moreover, the surviving cones were distributed in the whole retina, and not only localized in the areas of injection (data not shown).
We also examined the effect of RdCVF injection on cone function by measuring the photopic electroretinogram. An example of the photopic ERG response following RdCVF injections is provided in Figure 4d . RdCVF injections were found to limit the decrease in photopic ERG observed between 4 and 9 months (see Fig. 1d ). The amplitude of the photopic inserm-00464512, version 1 -17 Mar 2010 ERG B-wave in RdCVF injected eyes (Fig. 4e, 43±24 µV) was 115% and 126% higher respectively than in the contralateral control eyes (20±13 µV) and sham operated eyes (19±11 µV). The differences observed after RdCVF injection were statistically significant (p<0.01).
The scotopic responses however did not show any significant difference between all the groups examined. Thus, RdCVF protein administration is providing a selective protection of cone photoreceptor function.
The observation of a larger functional effect, as compared to cytoprotection (Fig. 4e   versus 4c ) led us to analyze the morphology of photoreceptors. Several reports document that changes in the length and morphology of outer segments occur prior to cell death and that they relate to functional alterations [21, 22] . The cones of wild-type retina (Fig. 5a ) displayed longer outer segments than those of P23H rat retina at 9 months of age (Fig. 5b) . The region surrounded by a white line with higher magnification corresponds to the diameter of the tip areas of cone outer segments on flat-mounted retinas. The tip areas of cone outer segments in P23H rat retina (Fig. 5b) were larger than in wild-type retina (Fig. 5a) . Such shortening of cone outer segments and the enlargement of the tip of cone outer segments on flat-mounted retinas imply that the P23H cones are dysmorphic which relates to dysfunction even before dying. As the enlargement of the tip of cone outer segments appears as a proper marker of this event, we compared the size of the tip area of cone outer segments from RdCVF treated, untreated control and sham retinas. We scanned the flat-mounted RdCVF-injected retinas (9 months of age) stained by PNA lectin using an automated acquisition system (Figs. 5c,d ). The measure was performed for five retinas of each group in 40 fields at 0.2 mm from the optic nerve in all directions. The areas of 5 to 25 cones in each field were measured in a masked test. In Figure 5i and Table 2 , the tip areas of cone outer segments in the RdCVF treated retinas (21±7 µm²) are 38% and 34% smaller respectively than in the untreated control retinas (34±10 µm²) and sham retinas (32±9 µm²). These differences after RdCVF injection were inserm-00464512, version 1 -17 Mar 2010 statistically significant (both, p<0.001). The correlation between cone outer segment morphology and cone function is even more apparent when the data of Figure 5i are plotted with those of Figure 4e , the data points then align in a strength lane with a regression R of 0.8939. To get more details on the morphology of the cones, the images acquired from 9 focus plans were reconstructed in 3D using Metamorph software and converted into 2D using the optimal focus as shown in Figure 5e and 5f. The surface of the selected cells is e-6.6 µm², f-4.5 µm². The hollow area inside is e-1.9 µm², f-0.8 µm². These data imply that the total surface of the selected cell and the inner hole area are smaller in RdCVF treated P23H retina than in untreated control P23H retina. Furthermore, we scanned the cone cells from both the RdCVF treated and non-treated retinas by using confocal microscope and we observed smaller, ellipse tip area (white star) and longer outer segment in the RdCVF treated retina (double arrow, Fig. 5h ), than in the non-treated retina (Fig. 5g) . Therefore RdCVF injection induced a morphological pattern resembling that observed in normal cones or prior to rod degeneration. This observation that the morphology of cone outer segments after RdCVF injection might be correlated with the increased response to light stimuli is scored in Figure   4e .
DISCUSSION
The importance of rod/cone interactions for cone survival was suggested subsequent to the identification of the first causal mutations in retinitis pigmentosa [23, 24] . Indeed, despite the fact that these causal genes are often solely expressed in rods, the degeneration of cones is nonetheless triggered [19, 25, 26] evidence that rod presence is required for cone survival [8] . The demonstration of the rod/cone dependence was directly provided by co-culture experiments [9] . These results were obtained by transplantation and co-culture in the rd1 mouse. Yet, this model has important limitations as rods degenerate before the complete differentiation of the photoreceptors.
Moreover, cone degeneration is observed at an age when no cone ERG signal can be recorded [12] . We have here used a rat model of RP in another species, the P23H transgenic rat, widely acknowledged as relevant for preclinical studies.
RdCVF was isolated for its effect on cone survival using embryonic chick cone cultures [11] . In the P23H rat retina, by 6 months of age most rods have degenerated and lost most of their function (Fig. 1, b and d) . The effect of the injections of RdCVF protein from 6 to 8 months indicates that this factor induces cone survival directly but does not act indirectly by stimulating rod survival, as most rods have already degenerated at the time of treatment.
Similarly, this trophic effect appears independent from the mechanisms of rod degeneration and thus of the causal mutation when the mutated gene is only expressed in rods. Indeed, although photoreceptors undergo apoptosis in both the rd1 mouse [32] and the P23H rat [1] , this apoptosis is attributed to the cGMP toxicity [33] and Ca 2+ fluxes in the rd1 mouse [34, 35] whereas, by contrast, in the P23H model, it is reported to result from a gain of function due to the toxicity of the mutated rhodopsin [36] . Therefore, RdCVF is very likely to act directly on cone survival but not to interfere with the mechanisms of rod degeneration. Furthermore, we also observed that cone photoreceptor distribution extended through the whole retina, but not localized in some areas, showing such an extent of the rescue may relate to the multiple subretinal injections and the spread achieved.
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Importantly, RdCVF induces also a functional rescue validating thereby the potential of this trophic factor for therapeutic applications. On account of the large variance observed in
ERGs between rats at the same age, we performed a paired student T-test for statistical analysis from each rat between the treated and untreated control eyes. On average, the cone numbers were increased by 20% and photopic ERG B-wave amplitudes were increased by 115%. In addition, by comparison between these P23H rats and wild type rats (201±63 µV),
we observed that photopic ERG B-wave amplitudes from the RdCVF protein injected eyes reached 43% of wild type, in contrast to only 10% in the non-injected eyes. The more evident improvement in the ERG measurement compared to overall cone number may indicate that the ratio of functional cones with respect to surviving cones was increased by RdCVF protein injection, implying that RdCVF has a direct effect on cone function. Moreover, ERG B-wave amplitude was about 30 µV when RdCVF injections were started (6 months), then it raised to over 40 µV (P<0.01) after repeated treatment, implying that this improvement might be due to changes in photoreceptor activity, changes in bipolar or horizontal cell function to photoreceptor input, or synaptic connectivity from the surviving cone. We suggest that it might be caused by changes of cone photoreceptor outer segments which were observed both in the photoreceptor transplanted and injected retinas. Recently it has been shown that exposing the P23H rat for one week to photopic ambient light results in the reduction of the cone B-wave amplitude by 57%, an effect that could not be explained by photoreceptor loss as the cone cell density was unchanged, but was associated with the shortening of cone outer segments [37] . In addition the cone outer segments were swollen, delaminated and vesiculated. Interestingly, after 5 weeks in scotopic conditions the cone B-wave amplitude recovered to 87%, while cone outer segments were reorganized and retrieved their elongated morphology. This demonstrates the capacity of cones to recover morphologically and functionally after photo-oxidative damage and that functional changes are better correlated
with cone outer segment morphology than with cone cell density. Furthermore, it has been demonstrated that RdCVF, which is homologous to the thioredoxin family is able to protect cone cells against light irradiation [38] . Correlations between photoreceptor outer segment morphology and ERG were also demonstrated [14] reporting that CNTF treatment after 6 days caused a shortening of rod outer segments and a suppression of ERG responses, and all these changes were fully reversible after 3 weeks. They found a 62% reduction in A 
For the treatment of patients with retinitis pigmentosa, the large number of genes and, in particular, the dominant inheritance of many types of RP is a major challenge for corrective gene therapy [40] . The neuroprotective effect of FGF2 in a rat model of inherited retinal dystrophy [41] initiated the search for the most potent protective factors, an approach that would offer therapeutic potential regardless of the causal mutation. CNTF is currently being evaluated in a clinical trial [15] , although the paradoxical decrease in both scotopic and photopic responses in CNTF-treated retinas [42] has led to the evaluation of other trophic factors such as glial cell derived neurotrophic factor, GDNF [12, 43, 44] . In addressing the secondary degeneration of cones, RdCVF administration may be used to target a pathological mechanism common to most forms of the disease. The retinal cone cells are responsible for all visual functions in normal light. Therefore, preventing their degeneration is a rational strategy in the treatment of RP patients. This objective is medically feasible since 50% cone loss does not result in significant loss of visual acuity [5] and furthermore it has been estimated that this approach may prevent up to 1.5 million people worldwide from becoming blind [6] .
The present study on the P23H rat suggests that RdCVF administration may be efficient in the treatment of autosomal dominant RP due to rhodopsin mutations, which 
MATERIALS AND METHODS
Animals
Experimental procedures adhered to the Association for Research in Vision and
Ophthalmology Statement for the Use of Animals in Ophthalmology and Vision Research. sequence is identical to that of the rat RdCVF gene mined in the genomic database (Fig. 2a) .
Rat RdCVF is 98% homologous to RdCVF from mouse (Fig. 2b) . There are two conservative changes in amino acid sequences: V2A and D106E.
Reverse transcription-Polymerase Chain Reaction (RT-PCR) analysis
Retinal total RNA from Sprague-Dawley and transgenic rats was purified using CsCl centrifugation and reverse transcribed into cDNAs by random hexamers (pdN 6 
RdCVF injection
Human RdCVF polypeptide (109 amino acids) was synthesised at GeneProt (Geneva) and refolded (>90% purity). The protective effect of the RdCVF synthetic protein on coneenriched cultures from chicken embryos was performed as previously described [11] . The injections were performed totally three times and monthly: at different post-natal month (6M, 7M and 8M). Before injections, rats were anesthetized by intramuscular injection of a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg). After anesthetizing, we exposed the superior sclera and performed a small hole by using a 10-0 needle. The induction of a local retinal detachment was checked in order to confirm the success of the subretinal injection procedure. The local retinal detachment was chosen at different locations to maximize inserm-00464512, version 1 -17 Mar 2010
delivery. The microsyringe (Hamilton, 10 µl) was then gently inserted into the subretinal space, and 3 µl of synthetic RdCVF protein (concentration: 0.5 µg/µl) was injected. We used the same procedure for sham surgery where only PBS was injected to the control eye.
Cell counts and measurement of the tip areas of cone outer segments
The total numbers of PNA-labeled cones were estimated in the flat-mounted retinas by using a stereological counting approach to achieve unbiased sampling, as previously described [9] . The rat retina was subdivided into 225 fields representing a surface of 1225 µm² each. A zone of 2 mm radius centre on the optic nerve was omitted in the counting. 120-200 fields distributed throughout the remaining whole retinal surface were chosen for cone counting by using a systematic random sampling procedure: an initial random choice was made for the first measurement, and all subsequent sampling was performed at predetermined intervals throughout the retinal surface. Each field was observed and the number of cone visually counted by using a Nikon Plan 40× objective on a Nikon photomicroscope equipped with a Sony Trinitron color graphic display camera (Sony, Tokyo). The counted cone numbers and fields were cumulated automatically by the computer during the counting. The average of cone number per field was calculated in order to estimate the number of cone photoreceptors per millimeter square. The cone counts were expressed as density over the estimated retinal surface.
To measure the tip areas of cone outer segments, the flat-mounted retinas were scanned by automated acquisition system, using a Nikon Plan 40× objective. We chose 5 retinas of morphology of the cones, the images built from 9 focus plans were reconstructed in 3D using
Metamorph software and converted into 2D using the optimal focus.
ERG recordings
Following overnight dark adaptation, animals were prepared for recording under dim red light. After intramuscular anaesthesia with a mixture of ketamine (100mg/kg) and xylazine (10mg/kg), pupils were dilated with 0.5% tropicamide or 1% atropine and the cornea was 
Statistical Analysis
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We used the method of Smirnov to distinguish whether the data followed a normal distribution. As we selected randomly one eye of each rat for the treated sample, and another eye for the control in all the groups of experiment, all the samples for ERG and cell counts were paired to compare treated vs. control retinas in each group (cone number of each mm² per retina, amplitude and latency of ERG A and B waves separately). Student's t test was performed for paired series-ERG and cell counts. Analysis of variance and t test were used for unpaired series-the size of the tip areas of cone outer segments. Table S1 . RdCVF injection: photopic B-wave amplitudes and cone counts of the RdCVF protein injected and contralateral controls eyes from P23H rats. 
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